| Income Statement |
| Total Revenue | 192.82M |
|
| Revenues (USD) | 192.82M |
| Cost of Revenue | 62.04M |
| Gross Profit | 130.79M |
| Operating Expenses | 99.56M |
| Research and Development Expense | 24.14M |
| Selling, General and Administrative Expense | 75.43M |
| Operating Income | 31.22M |
| Interest Expense | 6.31M |
| Income Tax Expense | 6.18M |
| Net Income | 19.37M |
| Net Income Common Stock | 19.37M |
| Net Income Common Stock (USD) | 19.37M |
| Consolidated Income | 19.37M |
| Earnings per Basic Share | 0.14 |
| Earnings per Basic Share (USD) | 0.14 |
| Earnings per Diluted Share | 0.13 |
| Earning Before Interest & Taxes (EBIT) | 31.86M |
| Earning Before Interest & Taxes (USD) | 31.86M |
| Weighted Average Shares | 143.02M |
| Weighted Average Shares Diluted | 147.17M |
| Balance Sheet |
| Cash and Equivalents | 332.62M |
| Cash and Equivalents (USD) | 332.62M |
| Trade and Non-Trade Receivables | 1.38B |
| Current Assets | 1.75B |
| Property, Plant & Equipment Net | 178.34M |
| Total Assets | 3.03B |
| Debt Current | 27.50M |
| Total Debt | 416.98M |
| Current Liabilities | 1.70B |
| Debt Non-Current | 389.48M |
| Total Liabilities | 2.10B |
| Accumulated Retained Earnings (Deficit) | -492.78M |
| Accumulated Other Comprehensive Income | -1.40M |
| Shareholders Equity | 936.27M |
| Shareholders Equity (USD) | 936.27M |
| Assets Non-Current | 1.29B |
| Total Debt (USD) | 416.98M |
| Goodwill and Intangible Assets | 1.02B |
| Liabilities Non-Current | 392.83M |
| Trade and Non-Trade Payables | 1.67B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 14.68M |
| Net Cash Flow from Financing | -22.33M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 147.97M |
| Capital Expenditure | -16.48M |
| Issuance (Purchase) of Equity Shares | -14.71M |
| Issuance (Repayment) of Debt Securities | -908.00K |
| Net Cash Flow from Investing | -16.48M |
| Net Cash Flow from Operations | 186.63M |
| Effect of Exchange Rate Changes on Cash | 143.00K |
| Share Based Compensation | 19.63M |